| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/09/2008 | EP1490053B1 Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and radiotherapy |
| 01/09/2008 | EP1453467A4 Methods and compositions for modulating apoptosis |
| 01/09/2008 | EP1446118B1 Oral dosage form of parecoxib |
| 01/09/2008 | EP1411980B1 Uses of dc-sign and dc-signr for inhibiting hepatitis c virus infection |
| 01/09/2008 | EP1409449B1 Alpha-ketoglutarates of active ingredients and compositions containing same |
| 01/09/2008 | EP1402890B1 Sulfonamide derivatives |
| 01/09/2008 | EP1400513B1 Unsymmetrical cyclic diamine compound |
| 01/09/2008 | EP1385845B1 N-aroyl cyclic amines |
| 01/09/2008 | EP1373218B1 Imidazolyl derivatives useful as histamine h3 receptor ligands |
| 01/09/2008 | EP1324766B1 Fgf-2 for the treatment of peripheral artery disease |
| 01/09/2008 | EP1318797B1 Volatile anaesthetic with xenon |
| 01/09/2008 | EP1315729B1 Compounds in the form of homodimeric or heterodimeric prodrugs; process for obtaining these prodrugs and their acceptable pharmaceutical salts and use of compounds in the treatment of phosphodiesterases-mediated diseases or dysfunction |
| 01/09/2008 | EP1311270B1 Non-sedating barbiturate compounds as neuroprotective agents |
| 01/09/2008 | EP1283043B1 Ophthalmic solution |
| 01/09/2008 | EP1282604B1 Substituted caprolactam carbonates and ethers and their use as anti-tumor agents |
| 01/09/2008 | EP1263730B1 Amine derivatives for the treatment of apoptosis |
| 01/09/2008 | EP1254176B1 Use of the extracellular domain of TRADE molecules in medicaments for treating neoplasia |
| 01/09/2008 | EP1223935B1 Use of gemifloxacin compounds against bacteria |
| 01/09/2008 | EP1176956B1 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors |
| 01/09/2008 | EP1129064B1 Transfection reagents |
| 01/09/2008 | EP1115416B1 Use of substances with oxytocin activity in order to create cell regeneration |
| 01/09/2008 | EP1044009B1 Methods and compositions employing red rice fermentation products |
| 01/09/2008 | EP0988042B1 Combination of product r and an antiviral agent in the therapy of hiv infections |
| 01/09/2008 | EP0866726B2 Pulmonary administration of dry powder alpha 1-antitrypsin |
| 01/09/2008 | EP0814789B2 Pharmaceutical compositions comprising monoamine oxidase b inhibitors |
| 01/09/2008 | CN101103121A Quercetin glycoside composition and method of preparing the same |
| 01/09/2008 | CN101103039A Erythromycin derivatives as antibacterial agents |
| 01/09/2008 | CN101103035A Triazolopyrimidine derivatives as glycogen synthase kinase 3 inhibitors |
| 01/09/2008 | CN101103034A Amino-imidazolones for the inhibition of beta-secretase |
| 01/09/2008 | CN101103033A Triazolophthalazines as PDE2-inhibitors |
| 01/09/2008 | CN101103032A 双环吡咯衍生物 Bicyclopyrrole derivatives |
| 01/09/2008 | CN101103031A Pyrrolo pyrimidine derivatives useful for treating proliferative diseases |
| 01/09/2008 | CN101103030A Medicaments with HM74A receptor activity |
| 01/09/2008 | CN101103029A 1,5,6-substituted-2-oxo-3-cyano-1,6a-diaza-tetrahydro-fluoranthenes as anti-infective agents |
| 01/09/2008 | CN101103027A 3,3-disubstituted tetrahydropyranyl cyclopentyl amide modulators of chemokine receptor activity |
| 01/09/2008 | CN101103026A Bicyclic heteroaryl derivatives for treating viruses |
| 01/09/2008 | CN101103023A Disubstituted ureas as kinase inhibitors |
| 01/09/2008 | CN101103022A New carboxylic acid amide used as XA inhititor |
| 01/09/2008 | CN101103020A Cgrp受体拮抗剂 Cgrp receptor antagonists |
| 01/09/2008 | CN101103019A 2-(cyclic aminocarbonyl)indoline derivative and medicinal composition containing the same |
| 01/09/2008 | CN101103017A Novel aminopyridine derivatives having Aurora-A selective inhibitory action |
| 01/09/2008 | CN101103016A Inhibitors of 11-beta hydroxyl steroid dehydrogenase type I and methods of using the same |
| 01/09/2008 | CN101103015A 5-thioxo-1,5-dihydro-2h-pyrrol-2-one derivatives as liver X receptor modulators |
| 01/09/2008 | CN101103013A 1-thio-D-glucitol derivatives |
| 01/09/2008 | CN101103012A Novel biaromatic compounds that modulate PPARgamma type receptors and cosmetic/pharmaceutical compositions comprised thereof |
| 01/09/2008 | CN101103011A Novel 2H-chromene derivatives as selective estrogen receptormodulators |
| 01/09/2008 | CN101103008A Macrocyclic compounds useful as bace inhibitors |
| 01/09/2008 | CN101103007A 酰胺化合物 Amide compounds |
| 01/09/2008 | CN101103004A Novel cis-imidazolines |
| 01/09/2008 | CN101103002A 3,4,(5)-substituted tetrahydropyridines |
| 01/09/2008 | CN101102995A Process for preparing substantially pure tolterodine tartrate |
| 01/09/2008 | CN101102994A Polymorphs of memantine hydrochloride |
| 01/09/2008 | CN101102989A Substituted cyclopentanes or cyclopentanones for the treatment of ocular hypertensive conditions |
| 01/09/2008 | CN101102988A Oxylipins from long chain polyunsaturated fatty acids and methods of making and using the same |
| 01/09/2008 | CN101102818A Medicaments comprising carbonyl compounds, and the use thereof |
| 01/09/2008 | CN101102816A Compositions comprising ornithine and phenylacetate or phenylbutyrate for treating hepatic encephalopathy |
| 01/09/2008 | CN101102797A 外用组合物 Topical compositions |
| 01/09/2008 | CN101102796A Benzothiazole formulations and use thereof |
| 01/09/2008 | CN101102795A Drug carrier and drug carrier kit for inhibiting fibrosis |
| 01/09/2008 | CN101102780A Hepatic function remedial agent |
| 01/09/2008 | CN101102779A Compositions comprising scyllo-inositol derivatives and methods to treat disorders of protein aggregation |
| 01/09/2008 | CN101102778A Substance mixture |
| 01/09/2008 | CN101102777A Drug and food or drink for improving pancreatic functions |
| 01/09/2008 | CN101102776A Antitumor agent |
| 01/09/2008 | CN101102775A Methods of using PDEV inhibitors for the treatment of congestive heart failure |
| 01/09/2008 | CN101102774A Intravenous formulations of PDE-5 inhibitors |
| 01/09/2008 | CN101102773A Aminopyrazine analogs for treating glaucoma and other RHO kinase-mediated diseases |
| 01/09/2008 | CN101102771A Methods and compositions using immunomodulatory compounds for treatment and management of central nervous system injury |
| 01/09/2008 | CN101102770A Amelioration of cataracts, macular degeneration and other ophthalmic diseases |
| 01/09/2008 | CN101102769A Synthesis of sodium narcistatin and related compounds |
| 01/09/2008 | CN101102768A Method and composition for the treatment of hyperlipidemia |
| 01/09/2008 | CN101102767A Methods and compositions using JNK inhibitors for treatment and management of central nervous system injury |
| 01/09/2008 | CN101102766A Novel derivatives of porphyrin, particularly chlorins and/orbacteriochlorins, and uses thereof in photodynamic therapy |
| 01/09/2008 | CN101102765A Tetrahydrocarbazoles as active agents for inhibiting VEGF production by translational control |
| 01/09/2008 | CN101102764A Methods of use of dual PPAR agonist compounds and drug delivery devices containing such compounds |
| 01/09/2008 | CN101102763A Composition for stimulating growth of dermal papilla cells and promoting hair follicle growth comprising vitamin C derivatives |
| 01/09/2008 | CN101102762A Compositions including iron |
| 01/09/2008 | CN101102761A Use of lignan compounds for treating or preventing inflammatory disease |
| 01/09/2008 | CN101102760A Methods and reagents for the treatment of immunoinflammatory disorders |
| 01/09/2008 | CN101102759A Glycine reuptake inhibitors for treating drug and alcohol dependence |
| 01/09/2008 | CN101102758A Thyroid hormone analogs for promoting angiogenesis |
| 01/09/2008 | CN101102757A Method for the treatment of polycystic kidney disease |
| 01/09/2008 | CN101102756A Pharmaceutical polymer composition for oral controlled-release delivery of terbutaline sulfate |
| 01/09/2008 | CN101102755A Use of renin inhibitors for the prevention or treatment of diastolic dysfunction or diastolic heart failure |
| 01/09/2008 | CN101102754A Transdermal pharmaceutical preparation with a progesterone a-specific ligand (PRASL) as active ingredient |
| 01/09/2008 | CN101102753A Pharmaceutical formulation comprising low crystallinity cellulose |
| 01/09/2008 | CN101102752A Combination therapy associating preferably a ceramide with acytotoxic drug |
| 01/09/2008 | CN101102751A Reverse micelle composition for delivery of metal cations comprising a diglyceride and a phytosterol and method of preparation |
| 01/09/2008 | CN101102744A Skin-whitening agent |
| 01/09/2008 | CN101102740A Medicinal composition and process for producing the same |
| 01/09/2008 | CN101102733A Macromolecule-containing sustained release intraocular implants and related methods |
| 01/09/2008 | CN101100514A Oil composition containing siloxane with good spreading property |
| 01/09/2008 | CN101100510A Calcium polyaspartate |
| 01/09/2008 | CN101100480A New etonogestrel esters |
| 01/09/2008 | CN101100474A Fluoroquinolone compound containing phosphate ester group and its preparation method and use |
| 01/09/2008 | CN101100472A 4-amino-5,6-substituted thiopheno [2,3-D] pyrimidines compound and its uses |
| 01/09/2008 | CN101100470A Tetranuclear bipyrane coumarin compound |
| 01/09/2008 | CN101100469A Novel crystal of doripenem, preparation method and use thereof |
| 01/09/2008 | CN101100468A Doriipenem hydrate crystal and preparation method thereof |
| 01/09/2008 | CN101100467A Piperidinopyrazoles compound and its preparation method and application |